Research Ethics and Policy Series (REPS): "From Discovery to Disclosure: The Wins and Woes of Returning Genetic Research Results" - Angela Bradbury, MD

From Discovery to Disclosure:

The Wins and Woes of Returning Genetic Research Results
 

Angela R. Bradbury, MD

Professor of Medicine (Hematology-Oncology)
Hospital of the University of Pennsylvania
Associate Professor, Medical Ethics & Health Policy

Large prospective cohort studies and biobanks using next-generation sequencing can identify actionable genetic results that may impact participants' and relatives’ health. While there is growing support for returning such results, questions remain about how to inform participants of their choices and how to communicate findings effectively. Most biobanks and research programs weren’t designed to return results, raising concerns about cost, infrastructure, and participant preferences. The RESPECT Research Program collects real-world empirical data on outcomes of returning genetic research results and implementation barriers and challenges to inform best practices for returning genetic research results.

Dr. Angela Bradbury is a physician scientist who completed her residency in internal medicine at the University of Chicago, where she later completed fellowships in hematology/oncology and clinical medical ethics. She is a Professor in the Department of Medicine, Division of Hematology-Oncology, at the University of Pennsylvania and has a secondary appointment in the Department of Medical Ethics and Health Policy. She is also the founder and Executive Director of the Penn Telegenetics Program, a national program offering remote genetic services to medical practices without access to genetic providers.

Lunch provided. Streaming available via Zoom.